Topics

Biogen announced that its R&D chief is leaving for a venture capital firm and CEO job, only six months after the high-profile failure of the company’s #Alzheimer’s drug. https://buff.ly/2mIqOdu 

04:00 EDT 2 Oct 2019 | STAT

Biogen announced that its R&D chief is leaving for a venture capital firm and CEO job, only six months after the high-profile failure of the company’s ’s drug. https://buff.ly/2mIqOdu 

Original Article: Biogen announced that its R&D chief is leaving for a venture capital firm and CEO job, only six months after the high-profile failure of the company’s #Alzheimer’s drug. https://buff.ly/2mIqOdu 

NEXT ARTICLE

More From BioPortfolio on "Biogen announced that its R&D chief is leaving for a venture capital firm and CEO job, only six months after the high-profile failure of the company’s #Alzheimer’s drug. https://buff.ly/2mIqOdu "

Quick Search

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...